Global Labeling Services : Overview

As a critical aspect of product lifecycle management, global labeling is one of the complex processes of the life sciences’ Regulatory environment. Due to constantly evolving Regulatory labeling requirements, organizations must ensure that the product information related to manufacturing, safety, and efficacy mentioned on the core labels is controlled by maintaining central or core reference product information.

A core labeling document (CDS-Core Data Sheet) is an internal Regulatory labeling document that serves as the company’s global reference document for a product. Core Labeling is used to communicate the company’s position to the appropriate stakeholders worldwide for the inclusion of safety and efficacy information on country-specific labels. Core labeling is to be prepared before or after the Regulatory approval (or another Regulatory pathway) to market a medicinal product worldwide.

The primary information of a core label is derived from the Investigator Brochure (IB) of a clinical trial and then continually revised by adding more information from post-marketing sources like post-marketing safety and efficacy studies and post-marketing surveillance data.

The Company Core Data Sheet (CCDS) may also be used as an attachment to a Periodic Safety Update Report (PSUR). In this context, all the safety information, mentioned in a CCDS ("Company Core Safety Information" or "CCSI") or a specifically identified (e.g., by bold print) subset of this safety information, serves as reference information for determining "listedness."

The CIOMS III/V and VI guidelines describe some general criteria regarding the inclusion of safety information in a CCDS/CCSI. However, labeling regulations, guidelines, and expectations have significantly changed and have become more specific since the CIOMS III and III/V reports were published. Taking these developments into account is crucial from a Regulatory and legal/litigation point of view. Equally important for the Regulatory viability and defensibility of CCDS and CCSI content and for global labeling harmonization are carefully drafted and effective rationales as well as supporting documentation (Clinical Overviews).

Freyr’s unique experience in the field of labeling, and specifically core labeling, makes it an ideal resource for companies that create or revise CCDS and Company Core Safety Information (CCSI), and harmonize local safety labeling. Freyr has expertise in the preparation of label justification documents and global deviation management to enable clients to remain prepared for deviations in the end result. Freyr’s experienced labeling team not only tracks the country-specific labeling standards for on-time implementation of the labeling changes but also provides cost-effective global labeling management consultation.


Global Labeling - Freyr Expertise

  • Global labeling management.
  • Create, review, and update Investigational Brochure (IB).
  • Create, review, and update Developmental Core Data Sheet (DCDS).
  • Create, review, and update Company Core Data Sheet (CCDS) or Core Safety Information (CSI)/Reference Safety Information (RSI).
  • Detailed literature search & review to substantiate the labeling content.
  • Create, review, and update Clinical Overviews (CO)/Justification Documents (JD).
  • Quality Check (QC) of core labels (IB, DCDS, CCDS, RSI, CO/JD).
  • Tracking and implementation of labeling changes.  
  • Label content change control management.
  • HA query management. 
  • Preparation of label justification documents.
  • Global deviation management.

Global Labeling - Freyr Advantages

  • Resources with in-depth Regulatory knowledge.
  • Expertise in successfully handling global and regional drug labeling for Fortune pharma clients across the globe like the USA, EUROPE, APAC, MENA, etc.
  • Global Regulatory expertise in covering life sciences organizations, viz. pharma, biotech, and nutrition manufacturers.
  • Highly qualified medical writers with extensive Regulatory labeling experience.
  • In-depth and updated understanding of the global labeling requirements and changes from multiple Health Authorities such as the USFDA, EMA, TGA, etc.
  • Dedicated compliance team tracking the status of Core and Company Core Data Sheet (CDS/CCDS) implementation in regional labels.
  • Highly experienced pharmaceutical, biotech, and nutrition Regulatory labeling professionals.

Streamline Your Product Lifecycle Management with Global Labeling


Consult Freyr